The role of the aryl hydrocarbon receptor in normal and malignant B cell development

Seminars in Immunopathology

Volumn 35, Issue 6, 2013, Pages 705-716

  Sherr, David H ^a   Monti, Stefano ^b  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aryl hydrocarbon receptor; B cell development; Lymphoma; Myeloma

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; DIOXIN; POLYCHLORINATED BIPHENYL; POLYCYCLIC AROMATIC HYDROCARBON;

B CELL LEUKEMIA; B CELL LYMPHOMA; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CHRONIC LYMPHATIC LEUKEMIA; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; HUMAN; HUMORAL IMMUNITY; LARGE CELL LYMPHOMA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NONHUMAN; ORGAN CULTURE; PLASMA CELL; PRIORITY JOURNAL; REVIEW; TUMOR MICROENVIRONMENT;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; ENVIRONMENTAL EXPOSURE; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOMA, B-CELL; RECEPTORS, ARYL HYDROCARBON;

EID: 84886086103     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-013-0390-8     Document Type: Review

References (138)

1. Green MR, Monti S, Dalla-Favera R, Pasqualucci L, Walsh NC, Schmidt-Supprian M, Kutok JL, Rodig SJ, Neuberg DS, Rajewsky K, Golub TR, Alt FW, Shipp MA, Manis JP (2011) Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program. Proc Natl Acad Sci U S A 108(7):2873-2878. doi: 10.1073/pnas.1019537108
2. Lai ZW, Fiore NC, Hahn PJ, Gasiewicz TA, Silverstone AE (2000) Differential effects of diethylstilbestrol and 2,3,7,8-tetrachlorodibenzo-p- dioxin on thymocyte differentiation, proliferation, and apoptosis in bcl-2 transgenic mouse fetal thymus organ culture. Toxicol Appl Pharmacol 168(1):15-24
3. Shepherd DM, Steppan LB, Hedstrom OR, Kerkvliet NI (2001) Anti-CD40 treatment of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-exposed C57Bl/6 mice induces activation of antigen presenting cells yet fails to overcome TCDD-induced suppression of allograft immunity. Toxicol Appl Pharmacol 170(1):10-22
4. Yamaguchi K, Matulka RA, Shneider AM, Toselli P, Trombino AF, Yang S, Hafer LJ, Mann KK, Tao XJ, Tilly JL, Near RI, Sherr DH (1997) Induction of PreB cell apoptosis by 7,12-dimethylbenz[a]anthracene in long-term primary murine bone marrow cultures. Toxicol Appl Pharmacol 147(2):190-203
5. Yamaguchi K, Near RI, Matulka RA, Shneider A, Toselli P, Trombino AF, Sherr DH (1997) Activation of the aryl hydrocarbon receptor/transcription factor and bone marrow stromal cell-dependent preB cell apoptosis. J Immunol 158(5):2165-2173
6. Kerkvliet NI, Steppan LB, Brauner JA, Deyo JA, Henderson MC, Tomar RS, Buhler DR (1990) Influence of the Ah locus on the humoral immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: evidence for Ah-receptor-dependent and Ah-receptor-independent mechanisms of immunosuppression. Toxicol Appl Pharmacol 105(1):26-36
7. Thurmond TS, Silverstone AE, Baggs RB, Quimby FW, Staples JE, Gasiewicz TA (1999) A chimeric aryl hydrocarbon receptor knockout mouse model indicates that aryl hydrocarbon receptor activation in hematopoietic cells contributes to the hepatic lesions induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 158(1):33-40
8. Thurmond TS, Staples JE, Silverstone AE, Gasiewicz TA (2000) The aryl hydrocarbon receptor has a role in the in vivo maturation of murine bone marrow B lymphocytes and their response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 165(3):227-236
9. Vorderstrasse BA, Steppan LB, Silverstone AE, Kerkvliet NI (2001) Aryl hydrocarbon receptor-deficient mice generate normal immune responses to model antigens and are resistant to TCDD-induced immune suppression. Toxicol Appl Pharmacol 171(3):157-164
10. Vogel C, Donat S, Dohr O, Kremer J, Esser C, Roller M, Abel J (1997) Effect of subchronic 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on immune system and target gene responses in mice: calculation of benchmark doses for CYP1A1 and CYP1A2 related enzyme activities. Arch Toxicol 71(6):372-382
11. Burleson GR, Lebrec H, Yang YG, Ibanes JD, Pennington KN, Birnbaum LS (1996) Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza virus host resistance in mice. Fundam Appl Toxicol 29(1):40-47
12. Vorderstrasse BA, Bohn AA, Lawrence BP (2003) Examining the relationship between impaired host resistance and altered immune function in mice treated with TCDD. Toxicology 188(1):15-28
13. Head JL, Lawrence BP (2009) The aryl hydrocarbon receptor is a modulator of anti-viral immunity. Biochem Pharmacol 77(4):642-653. doi: 10.1016/j.bcp.2008.10.031
14. Warren TK, Mitchell KA, Lawrence BP (2000) Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppresses the humoral and cell-mediated immune responses to influenza A virus without affecting cytolytic activity in the lung. Toxicol Sci 56(1):114-123
15. Lawrence BP, Vorderstrasse BA (2004) Activation of the aryl hydrocarbon receptor diminishes the memory response to homotypic influenza virus infection but does not impair host resistance. Toxicol Sci 79(2):304-314
16. Laiosa MD, Lai ZW, Thurmond TS, Fiore NC, DeRossi C, Holdener BC, Gasiewicz TA, Silverstone AE (2002) 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes alterations in lymphocyte development and thymic atrophy in hemopoietic chimeras generated from mice deficient in ARNT2. Toxicol Sci 69(1):117-124
17. Rhile MJ, Nagarkatti M, Nagarkatti PS (1996) Role of Fas apoptosis and MHC genes in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity of T cells. Toxicology 110(1-3):153-167
18. Blaylock BL, Holladay SD, Comment CE, Heindel JJ, Luster MI (1992) Exposure to tetrachlorodibenzo-p-dioxin (TCDD) alters fetal thymocyte maturation. Toxicol Appl Pharmacol 112:207-213
19. Tucker AN, Vore SJ, Luster MI (1986) Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmacol 29(4):372-377
20. Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ (1996) Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol 140(1):173-179
21. Staples JE, Murante FG, Fiore NC, Gasiewicz TA, Silverstone AE (1998) Thymic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are strictly dependent on aryl hydrocarbon receptor activation in hemopoietic cells. J Immunol 160(8):3844-3854
22. Ladics GS, Kawabata TT, White KL (1991) Suppression of the in vitro humoral immune response of mouse splenocytes by 7,12-dimethylbenz[a]anthracene metabolites and inhibition of immunosuppression by a-naphthoflavone. Toxicol Appl Pharmacol 110:31-44
23. Ladics GS, Kawabata TT, Munson AE, White KL Jr (1992) Evaluation of murine splenic cell type metabolism of benzo[a]pyrene and functionality in vitro following repeated in vivo exposure to benzo[a]pyrene. Toxicol Appl Pharmacol 116(2):258-266
24. De Jong WH, Kroese ED, Vos JG, Van Loveren H (1999) Detection of immunotoxicity of benzo[a]pyrene in a subacute toxicity study after oral exposure in rats. Toxicol Sci 50(2):214-220
25. Ward EC, Murray MJ, Lauer LD, House RV, Irons R, Dean JH (1984) Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice. I. Effects on humoral immunity and host resistance. Toxicol Appl Pharmacol 75(2):299-308
26. Holladay SD, Smith BJ (1995) Benzo[a]pyrene-induced alterations in total immune cell number and cell-surface antigen expression in the thymus, spleen and bone marrow of B6C3F1 mice. Vet Human Toxicol 37:99-104
27. Silkworth JB, Antrim L (1985) Relationship between Ah receptor-mediated polychlorinated biphenyl (PCB)-induced humoral immunosuppression and thymic atrophy. J Pharmacol Exp Ther 235(3):606-611
28. Silkworth JB, Antrim LA, Sack G (1986) Ah receptor mediated suppression of the antibody response in mice is primarily dependent on the Ah phenotype of lymphoid tissue. Toxicol Appl Pharmacol 86(3):380-390
29. Silkworth JB, Antrim L, Grabstein EM (1984) Correlations between polychlorinated biphenyl immunotoxicity, the aromatic hydrocarbon locus, liver microsomal enzyme induction in C57BL/6 and DBA/2 mice. Toxicol Appl Pharmacol 75:156
30. Nebert DW, Roe AL, Dieter MZ, Solis WA, Yang Y, Dalton TP (2000) Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol 59(1):65-85
31. Shimizu Y, Nakatsuru Y, Ichinose M, Takahashi Y, Kume H, Mimura J, Fujii-Kuriyama Y, Ishikawa T (2000) Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A 97(2):779-782
32. Ruiz-Vela A, Gonzalez de Buitrago G, Martinez AC (1999) Implication of calpain in caspase activation during B cell clonal deletion. EMBO J 18(18):4988-4998
33. Scott DW, Tuttle J, Livnat D, Haynes W, Cogswell JP, Keng P (1985) Lymphoma models for B-cell activation and tolerance. II. Growth inhibition by anti-mu of WEHI-231 and the selection and properties of resistant mutants. Cell Immunol 93(1):124-131
34. Quadri S, Qadri A, Mann KL, Sherr DH (2000) The bioflavonoid galangin blocks aryl hydrocarbon receptor (AhR) activation and polycyclic aromatic hydrocarbon-induced pre-B cell apoptosis. Mol Pharmacol 58:515-525
35. Mann KK, Doerre S, Schlezinger JJ, Sherr DH, Quadri S (2001) The role of NF-kappaB as a survival factor in environmental chemical-induced pre-B cell apoptosis. Mol Pharmacol 59(2):302-309
36. Ryu HY, Mann KK, Schlezinger JJ, Jensen B, Sherr DH (2003) Environmental chemical-induced pro/pre-B cell apoptosis: analysis of c-Myc, p27Kip1, and p21WAF1 reveals a death pathway distinct from clonal deletion. J Immunol 170(10):4897-4904
37. Ryu HY, Emberley JK, Schlezinger JJ, Allan LL, Na S, Sherr DH (2005) Environmental chemical-induced bone marrow B cell apoptosis: death receptor-independent activation of a caspase-3 to caspase-8 pathway. Mol Pharmacol 68(4):1087-1096
38. Teague JE, Ryu HY, Kirber M, Sherr DH, Schlezinger JJ (2010) Proximal events in 7,12-dimethylbenz[a]anthracene-induced, stromal cell-dependent bone marrow B cell apoptosis: stromal cell-B cell communication and apoptosis signaling. J Immunol 185(6):3369-3378
39. Page TJ, O'Brien S, Jefcoate CR, Czuprynski CJ (2002) 7,12-Dimethylbenz[a]anthracene induces apoptosis in murine pre-B cells through a caspase-8-dependent pathway. Mol Pharmacol 62(2):313-319
40. Near RI, Matulka RA, Mann KK, Gogate SU, Trombino AF, Sherr DH (1999) Regulation of preB cell apoptosis by aryl hydrocarbon receptor/transcription factor-expressing stromal/adherent cells. Proc Soc Exp Biol Med 221(3):242-252
41. Mann KK, Matulka RA, Hahn ME, Trombino AF, Lawrence BP, Kerkvliet NI, Sherr DH (1999) The role of polycyclic aromatic hydrocarbon metabolism in dimethylbenz[a]anthracene-induced pre-B lymphocyte apoptosis. Toxicol Appl Pharmacol 161(1):10-22. doi: 10.1006/taap.1999.8778
42. Heidel SM, Czuprynski CJ, Jefcoate CR (1998) Bone marrow stromal cells constitutively express high levels of cytochrome P4501B1 that metabolize 7,12-dimethylbenz[a]anthracene. Mol Pharmacol 54(6):1000-1006
43. Heidel SM, Holston K, Buters JT, Gonzalez FJ, Jefcoate CR, Czupyrynski CJ (1999) Bone marrow stromal cell cytochrome P4501B1 is required for pre-B cell apoptosis induced by 7,12-dimethylbenz[a]anthracene. Mol Pharmacol 56(6):1317-1323
44. Allan LL, Sherr DH (2005) Constitutive activation and environmental chemical induction of the aryl hydrocarbon receptor/transcription factor in activated human B lymphocytes. Mol Pharmacol 67(5):1740-1750. doi: 10.1124/mol.104.009100
45. Tanaka G, Kanaji S, Hirano A, Arima K, Shinagawa A, Goda C, Yasunaga S, Ikizawa K, Yanagihara Y, Kubo M, Kuriyama-Fujii Y, Sugita Y, Inokuchi A, Izuhara K (2005) Induction and activation of the aryl hydrocarbon receptor by IL-4 in B cells. Int Immunol 17(6):797-805
46. Marcus RS, Holsapple MP, Kaminski NE (1998) Lipopolysaccharide activation of murine splenocytes and splenic B cells increased the expression of aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator. J Pharmacol Exp Ther 287(3):1113-1118
47. Crawford RB, Holsapple MP, Kaminski NE (1997) Leukocyte activation induces aryl hydrocarbon receptor up-regulation, DNA binding, and increased Cyp1a1 expression in the absence of exogenous ligand. Mol Pharmacol 52(6):921-927
48. Wood SC, Jeong HG, Morris DL, Holsapple MP (1993) Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human tonsillar lymphocytes. Toxicology 81(2):131-143
49. Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SS, Kimura S, Nebert DW, Rudikoff S, Ward JM, Gonzalez FJ (1995) Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268(5211):722-726
50. Schlezinger JJ, Liu D, Farago M, Seldin DC, Belguise K, Sonenshein GE, Sherr DH (2006) A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis. Biol Chem 387(9):1175-1187. doi: 10.1515/BC.2006.145
51. Ma Q, Whitlock J (1996) The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Mol Cell Biol 16:2144-2150
52. Abdelrahim M, Smith R 3rd, Safe S (2003) Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells. Mol Pharmacol 63(6):1373-1381
53. Puga A, Marlowe J, Barnes S, Chang CY, Maier A, Tan Z, Kerzee JK, Chang X, Strobeck M, Knudsen ES (2002) Role of the aryl hydrocarbon receptor in cell cycle regulation. Toxicology 181-182:171-177
54. Marlowe JL, Knudsen ES, Schwemberger S, Puga A (2004) The aryl hydrocarbon receptor displaces p300 from E2F-dependent promoters and represses S-phase specific gene expression. J Biol Chem 279:29013-29022
55. Marlowe JL, Fan Y, Chang X, Peng L, Knudsen ES, Xia Y, Puga A (2008) The aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis. Mol Biol Cell 19(8):3263-3271
56. Puga A, Barnes SJ, Dalton TP, Chang C-Y, Knudsen ES, Maier MA (2000) Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J Biol Chem 275:2943-2950
57. Kim DW, Gazourian L, Quadri SA, Romieu-Mourez R, Sherr DH, Sonenshein GE (2000) The RelA NF-kB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene 19(48):5498-5506
58. Tian Y, Ke S, Denison MS, Rabson AB, Gallo MA (1999) Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J Biol Chem 274(1):510-515
59. Vogel CF, Li W, Wu D, Miller JK, Sweeney C, Lazennec G, Fujisawa Y, Matsumura F (2011) Interaction of aryl hydrocarbon receptor and NF-kappaB subunit RelB in breast cancer is associated with interleukin-8 overexpression. Arch Biochem Biophys 512(1):78-86. doi: 10.1016/j.abb.2011.05.011
60. Salas VM, Burchiel SW (1998) Apoptosis in Daudi human B cells in response to benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol. Toxicol Appl Pharmacol 151(2):367-376. doi: 10.1006/taap.1998.8455
61. Matikainen TM, Moriyama T, Morita Y, Perez GI, Korsmeyer SJ, Sherr DH, Tilly JL (2002) Ligand activation of the aromatic hydrocarbon receptor transcription factor drives Bax-dependent apoptosis in developing fetal ovarian germ cells. Endocrinology 143(2):615-620
62. Robles R, Morita Y, Mann KK, Perez GI, Yang S, Matikainen T, Sherr DH, Tilly JL (2000) The aryl hydrocarbon receptor, a basic helix-loop-helix transcription factor of the PAS gene family, is required for normal ovarian germ cell dynamics in the mouse. Endocrinology 141(1):450-453
63. Caruso JA, Mathieu PA, Joiakim A, Leeson B, Kessel D, Sloane BF, Reiners JJ Jr (2004) Differential susceptibilities of murine hepatoma 1c1c7 and Tao cells to the lysosomal photosensitizer NPe6: influence of aryl hydrocarbon receptor on lysosomal fragility and protease contents. Mol Pharmacol 65(4):1016-1028
64. Caruso JA, Mathieu PA, Joiakim A, Zhang H, Reiners JJ Jr (2006) Aryl hydrocarbon receptor modulation of TNFalpha-induced apoptosis and lysosomal disruption in a hepatoma model that is caspase-8 independent. J Biol Chem 281:10954-10967
65. Allan LL, Sherr DH (2010) Disruption of human plasma cell differentiation by an environmental polycyclic aromatic hydrocarbon: a mechanistic immunotoxicological study. Environ Health 9:15. doi: 10.1186/1476-069X-9-15
66. Schneider D, Manzan MA, Yoo BS, Crawford RB, Kaminski N (2009) Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-tetrachlorodibenzo- p-dioxin-mediated suppression of the IgM response by B cells. Toxicol Sci 108(2):377-388
67. Sulentic CE, Holsapple MP, Kaminski NE (1998) Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells. Mol Pharmacol 53(4):623-629
68. Sulentic CE, Holsapple MP, Kaminski NE (2000) Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p- dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway. J Pharmacol Exp Ther 295(2):705-716
69. Sulentic CE, Kang JS, Na YJ, Kaminski NE (2004) Interactions at a dioxin responsive element (DRE) and an overlapping kappaB site within the hs4 domain of the 3′alpha immunoglobulin heavy chain enhancer. Toxicology 200(2-3):235-246. doi: 10.1016/j.tox.2004.03.015
70. Sulentic CE, Zhang W, Na YJ, Kaminski NE (2004) 2,3,7,8- Tetrachlorodibenzo-p-dioxin, an exogenous modulator of the 3′alpha immunoglobulin heavy chain enhancer in the CH12.LX mouse cell line. J Pharmacol Exp Ther 309(1):71-78. doi: 10.1124/jpet.103.059493
71. Fernando TM, Ochs SD, Liu J, Chambers-Turner RC, Sulentic CE (2012) 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces transcriptional activity of the human polymorphic hs1,2 enhancer of the 3′Igh regulatory region. J Immunol 188(7):3294-3306. doi: 10.4049/jimmunol.1101111
72. Suh J, Jeon YJ, Kim HM, Kang JS, Kaminski NE, Yang KH (2002) Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells. Toxicol Appl Pharmacol 181(2):116-123
73. Genestier L, Taillardet M, Mondiere P, Gheit H, Bella C, Defrance T (2007) TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J Immunol 178(12):7779-7786
74. De Abrew KN, Phadnis AS, Crawford RB, Kaminski NE, Thomas RS (2011) Regulation of Bach2 by the aryl hydrocarbon receptor as a mechanism for suppression of B-cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 252(2):150-158. doi: 10.1016/j.taap.2011.01.020
75. Zhang Q, Kline DE, Bhattacharya S, Crawford RB, Conolly RB, Thomas RS, Andersen ME, Kaminski NE (2013) All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p- dioxin. Toxicol Appl Pharmacol 268(1):17-26. doi: 10.1016/j.taap.2013.01.015
76. Delogu A, Schebesta A, Sun Q, Aschenbrenner K, Perlot T, Busslinger M (2006) Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity 24(3):269-281. doi: 10.1016/j.immuni.2006.01.012
77. Mora-Lopez F, Reales E, Brieva JA, Campos-Caro A (2007) Human BSAP and BLIMP1 conform an autoregulatory feedback loop. Blood 110(9):3150-3157. doi: 10.1182/blood-2007-05-092262
78. De Abrew KN, Kaminski NE, Thomas RS (2010) An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation. Toxicol Sci 118(2):454-469. doi: 10.1093/toxsci/kfq265
79. Watson AJ, Hankinson O (1992) Dioxin- and Ah receptor-dependent protein binding to xenobiotic responsive elements and G-rich DNA studied by in vivo footprinting. J Biol Chem 267(10):6874-6878
80. Zhang L, Savas U, Alexander DL, Jefcoate CR (1998) Characterization of the mouse Cyp1B1 gene. Identification of an enhancer region that directs aryl hydrocarbon receptor-mediated constitutive and induced expression. J Biol Chem 273(9):5174-5183
81. Klapproth K, Wirth T (2010) Advances in the understanding of MYC-induced lymphomagenesis. Br J Haematol 149(4):484-497. doi: 10.1111/j.1365-2141.2010. 08159.x
82. Yang X, Liu D, Murray TJ, Mitchell GC, Hesterman EV, Karchner SI, Merson RR, Hahn ME, Sherr DH (2005) The aryl hydrocarbon receptor constitutively represses c-myc transcription in human mammary tumor cells. Oncogene 24(53):7869-7881
83. Nishimura R, Hata K, Matsubara T, Wakabayashi M, Yoneda T (2012) Regulation of bone and cartilage development by network between BMP signalling and transcription factors. J Biochem 151(3):247-254. doi: 10.1093/jb/mvs004
84. Smeets RL, Fleuren WW, He X, Vink PM, Wijnands F, Gorecka M, Klop H, Bauerschmidt S, Garritsen A, Koenen HJ, Joosten I, Boots AM, Alkema W (2012) Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling. BMC Immunol 13:12. doi: 10.1186/1471-2172-13-12
85. Ehrhardt GR, Hijikata A, Kitamura H, Ohara O, Wang JY, Cooper MD (2008) Discriminating gene expression profiles of memory B cell subpopulations. J Exp Med 205(8):1807-1817. doi: 10.1084/jem.20072682
86. Calame KL, Lin KI, Tunyaplin C (2003) Regulatory mechanisms that determine the development and function of plasma cells. Annu Rev Immunol 21:205-230
87. Jones SA, White CA, Robb L, Alexander WS, Tarlinton DM (2011) SOCS3 deletion in B cells alters cytokine responses and germinal center output. J Immunol 187(12):6318-6326. doi: 10.4049/jimmunol.1102057
88. Orkin SH, Zon LI (2008) Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132(4):631-644. doi: 10.1016/j.cell.2008.01.025
89. Chambers SM, Goodell MA (2007) Hematopoietic stem cell aging: wrinkles in stem cell potential. Stem Cell Rev 3(3):201-211
90. Chambers SM, Shaw CA, Gatza C, Fisk CJ, Donehower LA, Goodell MA (2007) Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol 5(8):e201. doi: 10.1371/journal.pbio.0050201
91. Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL (1996) The aging of hematopoietic stem cells. Nat Med 2(9):1011-1016
92. Christensen JL, Wright DE, Wagers AJ, Weissman IL (2004) Circulation and chemotaxis of fetal hematopoietic stem cells. PLoS Biol 2(3):E75. doi: 10.1371/journal.pbio.0020075
93. Jude CD, Climer L, Xu D, Artinger E, Fisher JK, Ernst P (2007) Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors. Cell Stem Cell 1(3):324-337. doi: 10.1016/j.stem.2007.05.019
94. Delgado MD, Leon J (2010) Myc roles in hematopoiesis and leukemia. Genes Cancer 1(6):605-616. doi: 10.1177/1947601910377495
95. Singh KP, Garrett RW, Casado FL, Gasiewicz TA (2011) Aryl hydrocarbon receptor-null allele mice have hematopoietic stem/progenitor cells with abnormal characteristics and functions. Stem Cells Dev 20(5):769-784. doi: 10.1089/scd.2010.0333
96. Van Zant G, Liang Y (2003) The role of stem cells in aging. Exp Hematol 31(8):659-672
97. Bell DR, Van Zant G (2004) Stem cells, aging, and cancer: inevitabilities and outcomes. Oncogene 23(43):7290-7296. doi: 10.1038/sj.onc.1207949
98. Lindsey S, Papoutsakis ET (2011) The aryl hydrocarbon receptor (AHR) transcription factor regulates megakaryocytic polyploidization. Br J Haematol 152(4):469-484. doi: 10.1111/j.1365-2141.2010.08548.x
99. van Grevenynghe J, Bernard M, Langouet S, Le Berre C, Fest T, Fardel O (2005) Human CD34-positive hematopoietic stem cells constitute targets for carcinogenic polycyclic aromatic hydrocarbons. J Pharmacol Exp Ther 314(2):693-702. doi: 10.1124/jpet.105.084780
100. Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, Lemischka IR (2002) A stem cell molecular signature. Science 298(5593):601-604. doi: 10.1126/science.1073823
101. Casado FL, Singh KP, Gasiewicz TA (2010) The aryl hydrocarbon receptor: regulation of hematopoiesis and involvement in the progression of blood diseases. Blood Cells Mol Dis 44(4):199-206. doi: 10.1016/j.bcmd.2010.01.005
102. Casado FL, Singh KP, Gasiewicz TA (2011) Aryl hydrocarbon receptor activation in hematopoietic stem/progenitor cells alters cell function and pathway-specific gene modulation reflecting changes in cellular trafficking and migration. Mol Pharmacol 80(4):673-682. doi: 10.1124/mol.111.071381
103. Gasiewicz TA, Singh KP, Casado FL (2010) The aryl hydrocarbon receptor has an important role in the regulation of hematopoiesis: implications for benzene-induced hematopoietic toxicity. Chem Biol Interact 184(1-2):246-251. doi: 10.1016/j.cbi.2009.10.019
104. Murante FG, Gasiewicz TA (2000) Hemopoietic progenitor cells are sensitive targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J mice. Toxicol Sci 54(2):374-383
105. Boitano AE, Wang J, Romeo R, Bouchez LC, Parker AE, Sutton SE, Walker JR, Flaveny CA, Perdew GH, Denison MS, Schultz PG, Cooke MP (2010) Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 329(5997):1345-1348. doi: 10.1126/science.1191536
106. Singh KP, Wyman A, Casado FL, Garrett RW, Gasiewicz TA (2009) Treatment of mice with the Ah receptor agonist and human carcinogen dioxin results in altered numbers and function of hematopoietic stem cells. Carcinogenesis 30(1):11-19. doi: 10.1093/carcin/bgn224
107. Singh KP, Casado FL, Opanashuk LA, Gasiewicz TA (2009) The aryl hydrocarbon receptor has a normal function in the regulation of hematopoietic and other stem/progenitor cell populations. Biochem Pharmacol 77(4):577-587. doi: 10.1016/j.bcp.2008.10.001
108. Carvajal-Gonzalez JM, Mulero-Navarro S, Roman AC, Sauzeau V, Merino JM, Bustelo XR, Fernandez-Salguero PM (2009) The dioxin receptor regulates the constitutive expression of the vav3 proto-oncogene and modulates cell shape and adhesion. Mol Biol Cell 20(6):1715-1727. doi: 10.1091/mbc.E08-05-0451
109. DiNatale BC, Schroeder JC, Perdew GH (2011) Ah receptor antagonism inhibits constitutive and cytokine inducible IL6 production in head and neck tumor cell lines. Mol Carcinog 50(3):173-183. doi: 10.1002/mc.20702
110. Barouki R, Coumoul X, Fernandez-Salguero PM (2007) The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett 581(19):3608-3615
111. Fernandez-Salguero PM (2010) A remarkable new target gene for the dioxin receptor: the Vav3 proto-oncogene links AhR to adhesion and migration. Cell Adh Migr 4(2):172-175
112. Ikuta T, Kawajiri K (2006) Zinc finger transcription factor Slug is a novel target gene of aryl hydrocarbon receptor. Exp Cell Res 312(18):3585-3594
113. Peng TL, Chen J, Mao W, Song X, Chen MH (2009) Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9. BMC Cell Biol 10:27. doi: 10.1186/1471-2121-10-27
114. Quintana PJ, Delfino RJ, Korrick S, Ziogas A, Kutz FW, Jones EL, Laden F, Garshick E (2004) Adipose tissue levels of organochlorine pesticides and polychlorinated biphenyls and risk of non-Hodgkin's lymphoma. Environ Heal Perspect 112(8):854-861
115. Hardell L, Eriksson M, Nordstrom M (2002) Exposure to pesticides as risk factor for non-Hodgkin's lymphoma and hairy cell leukemia: pooled analysis of two Swedish case-control studies. Leuk Lymphoma 43(5):1043-1049
116. Viel JF, Arveux P, Baverel J, Cahn JY (2000) Soft-tissue sarcoma and non-Hodgkin's lymphoma clusters around a municipal solid waste incinerator with high dioxin emission levels. Am J Epidemiol 152(1):13-19
117. Consonni D, Pesatori AC, Zocchetti C, Sindaco R, D'Oro LC, Rubagotti M, Bertazzi PA (2008) Mortality in a population exposed to dioxin after the Seveso, Italy, accident in 1976: 25 years of follow-up. Am J Epidemiol 167(7):847-858. doi: 10.1093/aje/kwm371
118. Ng CH, Janoo-Gilani R, Sipahimalani P, Gallagher RP, Gascoyne RD, Connors JM, Weber JP, Lai AS, Leach S, Le ND, Brooks-Wilson AR, Spinelli JJ (2010) Interaction between organochlorines and the AHR gene, and risk of non-Hodgkin lymphoma. Cancer Causes Control 21(1):11-22. doi: 10.1007/s10552-009-9429-5
119. Pesatori AC, Consonni D, Rubagotti M, Grillo P, Bertazzi PA (2009) Cancer incidence in the population exposed to dioxin after the "Seveso accident": twenty years of follow-up. Environ Health 8:39. doi: 10.1186/1476-069X-8-39
120. Barhoover MA, Hall JM, Greenlee WF, Thomas RS (2010) Aryl hydrocarbon receptor regulates cell cycle progression in human breast cancer cells via a functional interaction with cyclin-dependent kinase 4. Mol Pharmacol 77(2):195-201. doi: 10.1124/mol.109.059675
121. Gramatzki D, Pantazis G, Schittenhelm J, Tabatabai G, Kohle C, Wick W, Schwarz M, Weller M, Tritschler I (2009) Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells. Oncogene 28(28):2593-2605. doi: 10.1038/onc.2009.104
122. Moennikes O, Loeppen S, Buchmann A, Andersson P, Ittrich C, Poellinger L, Schwarz M (2004) A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice. Cancer Res 64(14):4707-4710
123. Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, Schumacher T, Jestaedt L, Schrenk D, Weller M, Jugold M, Guillemin GJ, Miller CL, Lutz C, Radlwimmer B, Lehmann I, von Deimling A, Wick W, Platten M (2011) An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478(7368):197-203. doi: 10.1038/nature10491
124. Yang X, Solomon S, Fraser LR, Trombino AF, Liu D, Sonenshein GE, Hestermann EV, Sherr DH (2008) Constitutive regulation of CYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue. J Cell Biochem 104(2):402-417. doi: 10.1002/jcb.21630
125. Belguise K, Guo S, Yang S, Rogers AE, Seldin DC, Sherr DH, Sonenshein GE (2007) Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype. Cancer Res 67(24):11742-11750. doi: 10.1158/0008-5472.CAN-07-2730
126. Brooks J, Eltom SE (2011) Malignant transformation of mammary epithelial cells by ectopic overexpression of the aryl hydrocarbon receptor. Curr Cancer Drug Targets 11(5):654-669
127. Kashuba EV, Gradin K, Isaguliants M, Szekely L, Poellinger L, Klein G, Kazlauskas A (2006) Regulation of transactivation function of the aryl hydrocarbon receptor by the Epstein-Barr virus-encoded EBNA-3 protein. J Biol Chem 281(2):1215-1223. doi: 10.1074/jbc.M509036200
128. Vogel CF, Li W, Sciullo E, Newman J, Hammock B, Reader JR, Tuscano J, Matsumura F (2007) Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression. Am J Pathol 171(5):1538-1548. doi: 10.2353/ajpath.2007.070406
129. Secchiero P, Barbarotto E, Gonelli A, Tiribelli M, Zerbinati C, Celeghini C, Agostinelli C, Pileri SA, Zauli G (2005) Potential pathogenetic implications
130. Chang X, Fan Y, Karyala S, Schwemberger S, Tomlinson CR, Sartor MA, Puga A (2007) Ligand-independent regulation of transforming growth factor beta1 expression and cell cycle progression by the aryl hydrocarbon receptor. Mol Cell Biol 27(17):6127-6139
131. Haarmann-Stemmann T, Bothe H, Abel J (2009) Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways. Biochem Pharmacol 77(4):508-520. doi: 10.1016/j.bcp.2008.09. 013
132. Allan LL, Mann KK, Matulka RA, Ryu HY, Schlezinger JJ, Sherr DH (2003) Bone marrow stromal-B cell interactions in polycyclic aromatic hydrocarbon-induced pro/pre-B cell apoptosis. Toxicol Sci 76(2):357-365. doi: 10.1093/toxsci/kfg239
133. Jensen BA, Leeman RJ, Schlezinger JJ, Sherr DH (2003) Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology study. Environ Health 2(1):16. doi: 10.1186/1476-069X-2-16
134. Perez LE, Parquet N, Shain K, Nimmanapalli R, Alsina M, Anasetti C, Dalton W (2008) Bone marrow stroma confers resistance to Apo2 ligand/TRAIL in multiple myeloma in part by regulating c-FLIP. J Immunol 180(3):1545-1555
135. Clarke CA, Glaser SL (2002) Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 94(7):2015-2023. doi: 10.1002/cncr.10403
136. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95(25):14863-14868
137. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545-15550. doi: 10.1073/pnas.0506580102
138. Carsetti R, Kohler G, Lamers MC (1995) Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med 181(6):2129-2140